Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys in HBeAg-negative Chronic Hepatitis B
NCT02570191Phase 4Completed
- Sponsor
- Roche
- Start
- Nov 2004
- Primary completion
- Feb 2007
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started Nov 2004; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02570191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570191.